Biokit is a biotechnology company that is part of Werfen with more than 45 years dedicated to the research, development and manufacture of Assay and Biomaterial for In Vitro diagnostics use.
Biokit is one of the world's leading OEM (Original Equipment Manufacturer) companies in the development and manufacture of customized products and solutions (Assays and Biomaterials) for the In Vitro Diagnostics industry.
Biokit ranks among the top Centres of Excellence and all its products and services satisfy stringent quality requirements and fully meet the particular needs of many different markets to promote greater laboratory efficiency and better clinical outcomes for patients.
All activities are strongly focused on three major values: Delivery to Results, Leadership and Management and Integrity.
Biokit, integral part of Werfen
Werfen is a growing, privately held corporation that was founded in 1966 in Barcelona, Spain.
We are a worldwide leader in in vitro diagnostics (IVD) in the specialties of Hemostasis, Acute Care Diagnostics and Autoimmunity.
At present, we operate directly in nearly 30 countries and in more than 100 territories through distributors. Our R&D and production centers are located in the United States and Europe. In 2018, our consolidated sales were 1,359M€ and we had an average workforce of 5,155 people.
DELIVERY OF RESULTS
Quality & Excellence, With A Customer Focus
We are thoroughly committed to accomplishing our mission and strategic long-term goals. We are dedicated to exceeding our customers’ and stakeholders’ expectations and going the extra mile that sets us apart from others.
Leadership and management
Teamwork Meets Innovation
We are dedicated to solid leadership and collaborative teamwork that allows us to carry out the strategy and the mission of our company in a purposeful way. We continue to invest in innovation, as it is the catalyst for the growth and success of our business and the key to our competitive advantage.
Honesty, Humillity, and Respect for People
We always live up to our words. We say what we mean and we mean what we say. We are direct and straightforward and we deliver according to the expectations we have generated., allowing us to build trust and credibility among our customers and stakeholders.
Biokit in figures
+191M€ Sales in 2019
+10% CAGR over the last 10 years
+8% Sustained R&D investment over sales ratio
+98% Export sales
+50 OEM partners
7 of the TOP-10 IVD players are our OEM partners
+100 countries where our products are present
+70 Million of Patient’s samples analyzed per year
+5 Patient’s samples are analyzed every second
+35,000m2 state-of-the-art Facilities in Barcelona, Spain
+3,500m2 dedicated to R&D activities
+9,200m2 dedicated to Manufacturing activities
+2,600m2 dedicated to Filling & Packaging activities
10 Automated Liquid Filling Lines & 3 Lyophilizers
ISO 8 classified areas for Production and Filling
+200 Chromatographic columns
+160 Liters of Chemiluminescent Microparticles per batch
+500 Liters of Buffer per batch
+300 Liters of Latex reagents per batch
+8 Million of vials filled per year
+50.000 Lyophilized vials per batch
+15.000 Kits packed per batch
+1.4 Million Kits packed per year
+200 Biomaterials Developed & Manufactured
+85 Chemiluminescence Assays Developed & Manufactured
+50 Latex Assays Developed & Manufactured
110 Immunoassay analyzers (CLIA and Clinical Chemistry)
66 Clinical Studies performed in the last 5 years (25 in USA)
+150 Million of IVD tests manufactured every year
+600 references in manufacturing
+50 Assays and Biomaterials launched in the last 5 years
CE mark, FDA (510k), NMPA and other registrations
It All Starts with People
We believe that the quality of the products we offer to our customers depends on our people.
Biokit promotes teamwork, fostering growth and personal initiative within a solid company that offers a challenging and diverse work environment.
Please contact us directly via telephone or with the following form.
Tel. +34 93 860 90 00